Act Capital Management, LLC Transcode Therapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Transcode Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 6,500 shares of RNAZ stock, worth $2,925. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,500
Previous 6,500
-0.0%
Holding current value
$2,925
Previous $8,000
12.5%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RNAZ
# of Institutions
1Shares Held
6.5KCall Options Held
0Put Options Held
0About Transcode Therapeutics, Inc.
- Ticker RNAZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,977,200
- Market Cap $5.84M
- Description
- TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...